Eric Moessinger
Direttore/Membro del Consiglio presso Amphivena Therapeutics, Inc.
Provenienza dei contatti di primo grado di Eric Moessinger
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Biotechnology | 21 | |
NanoDimension Management Ltd.
 NanoDimension Management Ltd. Investment ManagersFinance NanoDimension Management Ltd is a venture capital firm founded in 2002 by Aymeric Sallin. The firm is headquartered in George Town.
19
| Private Company | Investment Managers | 19 |
Emulate, Inc.
 Emulate, Inc. Drugstore ChainsRetail Trade Emulate, Inc. owns and operates Organs-on-Chips platform which acts as an automated human bioemulation platform for mimicking true human physiology. The firm's product responses to medicines, chemicals, and diseases can be predicted. The company was founded by James Coon, Donald Ingber and Geraldine Hamilton in July 2014 and is headquartered in Cambridge, MA.
11
| Holding Company | Drugstore Chains | 11 |
Visby Medical, Inc.
 Visby Medical, Inc. BiotechnologyHealth Technology Visby Medical, Inc. operates as a healthcare technology company. It develops diagnostic products for professionals and consumers. The company was founded by Gregory Loney and Adam de la Zerda in 2008 and is headquartered in San Jose, CA.
11
| Holding Company | Biotechnology | 11 |
Airna, Inc.
 Airna, Inc. Miscellaneous Commercial ServicesCommercial Services Airna, Inc. is an American company that focuses on the discovery and development of RNA editing therapeutics. Airna was founded by Thorsten Stafforst, Jin Billy Li, Tobias Merkle, Paul Vogel. The CEO is Kris Elverum.
9
| Holding Company | Miscellaneous Commercial Services | 9 |
Amphivena Therapeutics, Inc.
 Amphivena Therapeutics, Inc. Drugstore ChainsRetail Trade Amphivena Therapeutics, Inc. provides drug discovery services. It develops tetravalent, T-cell redirecting bispecific antibodies for the treatment of hematologic malignancies. The firm’s’ lead drug candidate is AMV-564, a CD33/CD3-targeting treatment for acute myeloid leukemia (AML), which Amphivena is currently preparing to advance into clinical development. The company was founded by Jeanmarie Guenot in December 2012 and is headquartered in San Francisco, CA.
6
| Holding Company | Drugstore Chains | 6 |
Partillion Bioscience Corp.
 Partillion Bioscience Corp. Miscellaneous Commercial ServicesCommercial Services Partillion Bioscience Corp. is an American company that specializes in providing a functional single-cell biology reagent platform. The company's nanovial technology allows for single-cell secretion analysis and other research capabilities. The company was founded by Joseph Michael de Rutte and Dino Di Carlo, with Joseph Michael de Rutte serving as CEO since incorporation.
5
| Holding Company | Miscellaneous Commercial Services | 5 |
Serotiny, Inc.
 Serotiny, Inc. Miscellaneous Commercial ServicesCommercial Services Serotiny, Inc. is an ecological adaptation exhibited by some seed plants. The company was founded in Justin Farlow and Colin Farlow and is headquartered in San Francisco, CA.
3
| Holding Company | Miscellaneous Commercial Services | 3 |
Pulse Therapeutics, Inc.
 Pulse Therapeutics, Inc. Electronic Equipment/InstrumentsElectronic Technology Pulse Therapeutics, Inc. provides medical devices to destroy blood clots. Its devices help in treating the stroke, heart disease and other conditions. Its products include MED System which helps in dissolve blood clots. The company was founded by Francis M. Creighton and Rogers Ritter in 2008 and is headquartered in St. Louis, Mo.
1
| Subsidiary | Electronic Equipment/Instruments | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Eric Moessinger tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| Stanford University | College/University | Undergraduate Degree Graduate Degree Doctorate Degree Graduate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
Ultivue, Inc.
 Ultivue, Inc. BiotechnologyHealth Technology Ultivue, Inc. engages in provision of biotechnology services. It offers super-resolution imaging, single-molecule and diagnostics services. Its product Multiplex IHC Reagent Kits, a performance marker multiplexing detection and analysis.The company was founded by Peng Yin, David Walt and Ralf Jumgmann in 2015 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Investment Managers | Founder Private Equity Investor Comptroller/Controller/Auditor | |
| Swiss Federal Institute of Technology | College/University | President Graduate Degree Director/Board Member | |
Qiming US Ventures Management, LLC
 Qiming US Ventures Management, LLC Investment ManagersFinance Qiming US Ventures Management LLC (Qiming Venture Partners) is a venture capital subsidiary of Qiming Venture Partners Ltd founded in 2017 by Mark D. McDade and Gary Edward Rieschel. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Founder Private Equity Investor Private Equity Investor | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
| University of Massachusetts | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| TWIST BIOSCIENCE CORPORATION | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Vandria SA
 Vandria SA Pharmaceuticals: MajorHealth Technology Vandria SA is a Swiss-based company that specializes in mitochondrial therapeutics. The company is based in Lausanne, Switzerland. The company is developing mitophagy inducers that rejuvenate cells to treat age-related and chronic diseases. Its lead program, VNA-318, is a brain-penetrant, patent-protected, mitophagy inducer that has shown to improve memory and learning and to have strong disease-modifying effects in models of neurodegenerative diseases such as Alzheimer's and Parkinson's disease. Vandria is also developing mitophagy-inducing small molecules to address muscle, lung, and liver diseases, as well as a separate program that targets ferroptosis. The company was founded by Patrick Aebischer, Chris Rinsch, and Johan Auwerx in 2021 and has raised $20.60m in venture finance. Klaus Dugi has been the CEO of the company since 2021. | Pharmaceuticals: Major | Founder Director/Board Member Chief Executive Officer | |
| University of California, Berkeley | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
Blade Therapeutics, Inc.
 Blade Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Blade Therapeutics, Inc. offers anti-fibrotic therapies to meet unserved patient needs. Its product portfolio is to address various fibrotic diseases and their underlying pathophysiology. The company was founded by Hal Dietz and Wendye R. Robbins and is headquartered in South San Francisco, CA. | Miscellaneous Commercial Services | Founder Director/Board Member Director/Board Member | |
Inspirna, Inc.
 Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Asceneuron SA
 Asceneuron SA Pharmaceuticals: MajorHealth Technology Asceneuron SA operates as a biotechnology company. It develops therapeutics for orphan tauopathis and Alzheimer?s disease. The firm specializes in small molecule drug discovery for neurodegenerative diseases. The company was founded by Dirk Beher, Frank Murdoch Armstrong and Christoph Wiessner in October 2012 and is headquartered in Lausanne, Switzerland. | Pharmaceuticals: Major | Chairman President | |
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
True North Therapeutics, Inc.
 True North Therapeutics, Inc. BiotechnologyHealth Technology True North Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of first-in-class product candidates for complement-mediated diseases. The company was founded by Nancy E. Stagliano in 2013 and is headquartered in South San Francisco, CA. | Biotechnology | Founder Chief Executive Officer | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Public Communications Contact | |
Comet Therapeutics, Inc.
 Comet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Comet Therapeutics, Inc. develops and commercializes treatments for patients suffering from metabolic, neurological and immunological disorders. The company was founded by Angellina Sekirnik and Enej Kuscer in 2008 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| ILLUMINA, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Human Resources Officer | |
| REVVITY, INC. | Medical Specialties | Corporate Officer/Principal Director/Board Member | |
| The University of Chicago | College/University | Masters Business Admin Masters Business Admin | |
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| EPIZYME, INC. | Biotechnology | Public Communications Contact Chief Tech/Sci/R&D Officer | |
| QUANTERIX CORPORATION | Medical Specialties | Director/Board Member Chairman | |
| 10X GENOMICS, INC. | Biotechnology | Corporate Officer/Principal Director/Board Member | |
| BIO-RAD LABORATORIES, INC. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| Ben-Gurion University of the Negev | College/University | Undergraduate Degree Graduate Degree | |
| University of Geneva | College/University | Doctorate Degree Doctorate Degree | |
| 908 DEVICES INC. | Medical Specialties | Director/Board Member Director/Board Member | |
| University of Virginia | College/University | Graduate Degree Undergraduate Degree | |
Arbor Biotechnologies, Inc.
 Arbor Biotechnologies, Inc. BiotechnologyHealth Technology Arbor Biotechnologies, Inc. engages in curating genetic biodiversity and discover novel protein functions from nature. The company was founded by David Arthur Svott, Winston Xia Yan, Feng Zhang and David R. Walt in 2016 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Chief Executive Officer | |
| The University of California, San Francisco | College/University | Doctorate Degree Doctorate Degree | |
| École Polytechnique Fédérale de Lausanne | College/University | President Graduate Degree | |
| University of Illinois | College/University | Undergraduate Degree Doctorate Degree | |
| TELESIS BIO, INC. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
SR One Capital Management LP
 SR One Capital Management LP Investment ManagersFinance SR One Capital Management LP (SR One) is a venture capital firm founded in 2020. The firm is headquartered in Redwood, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
| PFIZER, INC. | Pharmaceuticals: Major | Human Resources Officer Corporate Officer/Principal | |
| Stanford University School of Medicine | College/University | Graduate Degree Doctorate Degree | |
| STANDARD BIOTOOLS INC. | Medical Specialties | Director/Board Member Director/Board Member | |
| Yale University | College/University | Undergraduate Degree Doctorate Degree | |
| University of California, Irvine | College/University | Graduate Degree Masters Business Admin | |
Arctos Medical AG
 Arctos Medical AG BiotechnologyHealth Technology Arctos Medical AG engages in the acquisition, development, holding, registration, management, disposal, and exploitation of intellectual property rights and similar assets in the medical sector. These include patents, trademarks, licenses, industrial property rights, and inventions. The company was founded on June 6, 2012 and is headquartered in Bern, Switzerland. | Biotechnology | Chairman Founder | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Investor Relations Contact | |
| Indiana University | College/University | Doctorate Degree Undergraduate Degree | |
| NUVALENT, INC. | Biotechnology | Director/Board Member Director of Finance/CFO | |
| BOSTON SCIENTIFIC CORPORATION | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| Analytical Life Science & Diagnostics Association | Director/Board Member Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 43 |
| Svizzera | 6 |
| Germania | 2 |
| Israele | 2 |
Settori
| Health Technology | 26 |
| Consumer Services | 18 |
| Finance | 5 |
| Commercial Services | 3 |
Posizioni
| Director/Board Member | 387 |
| Corporate Officer/Principal | 130 |
| Independent Dir/Board Member | 71 |
| Founder | 60 |
| Chief Executive Officer | 56 |
Contatti più connessi
| Insiders | |
|---|---|
| Keith Crandell | 43 |
| Luke Evnin | 42 |
| Paul Conley | 39 |
| Amit Dilip Shah | 36 |
| Mark McDade | 35 |
| Patrick Aebischer | 34 |
| Frank R. Witney Witney | 31 |
| Martin Madaus | 30 |
| Ittai Harel | 22 |
| Sapna R. Srivastava | 21 |
| Zafrira Avnur | 20 |
| John Kuo | 19 |
| Julian Nikolchev | 17 |
| Isaac E. Ciechanover | 16 |
| Luc Bauer | 16 |
- Borsa valori
- Insiders
- Eric Moessinger
- Connessioni Società
